Group 2E: Brain Metastasis Screening; Liver Metastasis

Name: Group 2E: Brain Metastasis Screening; Liver Metastasis
Start: 2023-12-14
End: 2023-12-14

Poster #PO5-25-01: Treating liver metastases by reversing cell competition between metastatic cancer cells and hepatocytes.

Poster #PO2-27-09: Clinical impact of routine MRI screening for brain metastases in patients with HER2 positive or triple negative metastatic breast cancer.